Continue to site >
Trending ETFs

Name

As of 11/01/2024

Price

Aum/Mkt Cap

YIELD

Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.

Exp Ratio

Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.

Watchlist

$43.82

$560 M

0.00%

1.10%

Vitals

YTD Return

3.9%

1 yr return

8.9%

3 Yr Avg Return

-3.0%

5 Yr Avg Return

2.5%

Net Assets

$560 M

Holdings in Top 10

43.2%

52 WEEK LOW AND HIGH

$43.5
N/A
N/A

Expenses

OPERATING FEES

Expense Ratio 1.10%

SALES FEES

Front Load N/A

Deferred Load N/A

TRADING FEES

Turnover 49.00%

Redemption Fee N/A


Min Investment

Standard (Taxable)

N/A

IRA

N/A


Fund Classification

Fund Type

Closed-end mutual fund


Name

As of 11/01/2024

Price

Aum/Mkt Cap

YIELD

Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.

Exp Ratio

Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.

Watchlist

$43.82

$560 M

0.00%

1.10%

XBMEX - Profile

Distributions

  • YTD Total Return 3.9%
  • 3 Yr Annualized Total Return -3.0%
  • 5 Yr Annualized Total Return 2.5%
  • Capital Gain Distribution Frequency N/A
  • Net Income Ratio 0.01%
DIVIDENDS
  • Dividend Yield 0.0%
  • Dividend Distribution Frequency Monthly

Fund Details

  • Legal Name
    Blackrock Health Sciences Trust
  • Fund Family Name
    BlackRock
  • Inception Date
    May 02, 2005
  • Shares Outstanding
    13047269
  • Share Class
    Other
  • Currency
    USD
  • Domiciled Country
    United States
  • Manager
    Erin Xie

Fund Description


XBMEX - Performance

Return Ranking - Trailing

Period XBMEX Return Category Return Low Category Return High Rank in Category (%)
YTD 3.9% -26.9% 24.4% 86.79%
1 Yr 8.9% -7.8% 49.2% 96.86%
3 Yr -3.0%* -32.5% 9.5% 76.97%
5 Yr 2.5%* -4.9% 13.7% 91.10%
10 Yr 6.0%* 0.1% 13.3% 74.77%

* Annualized

Return Ranking - Calendar

Period XBMEX Return Category Return Low Category Return High Rank in Category (%)
2023 -2.6% -12.6% 19.0% 84.28%
2022 -9.7% -53.9% 3.2% 28.29%
2021 5.0% -39.6% 24.2% 32.24%
2020 10.9% -13.6% 178.2% 63.76%
2019 14.8% 3.8% 63.8% 83.46%

Total Return Ranking - Trailing

Period XBMEX Return Category Return Low Category Return High Rank in Category (%)
YTD 3.9% -26.9% 24.4% 86.79%
1 Yr 8.9% -7.8% 49.2% 96.86%
3 Yr -3.0%* -32.5% 9.5% 76.97%
5 Yr 2.5%* -4.9% 13.7% 91.10%
10 Yr 6.0%* 0.1% 13.3% 74.77%

* Annualized

Total Return Ranking - Calendar

Period XBMEX Return Category Return Low Category Return High Rank in Category (%)
2023 -2.6% -12.6% 19.0% 89.31%
2022 -9.7% -53.9% 3.7% 38.16%
2021 5.0% -33.9% 26.0% 71.05%
2020 10.9% -0.7% 180.6% 93.29%
2019 18.6% 4.6% 63.8% 93.23%

NAV & Total Return History


XBMEX - Holdings

Concentration Analysis

XBMEX Category Low Category High XBMEX % Rank
Net Assets 560 M 6.87 M 47.2 B 55.97%
Number of Holdings 318 26 430 2.52%
Net Assets in Top 10 256 M 2.12 M 22.1 B 57.23%
Weighting of Top 10 43.17% 18.4% 79.7% 66.04%

Top 10 Holdings

  1. UnitedHealth Group Inc 9.45%
  2. BlackRock Liquidity T-Fund Instl 4.82%
  3. Johnson & Johnson 4.40%
  4. Eli Lilly and Co 4.05%
  5. Thermo Fisher Scientific Inc 3.96%
  6. Pfizer Inc 3.78%
  7. Abbott Laboratories 3.45%
  8. AbbVie Inc 3.26%
  9. Danaher Corp 3.05%
  10. Medtronic PLC 2.99%

Asset Allocation

Weighting Return Low Return High XBMEX % Rank
Stocks
93.97% 87.34% 106.13% 87.42%
Cash
5.46% 0.00% 33.01% 16.98%
Other
0.42% -22.99% 23.24% 18.87%
Bonds
0.15% 0.00% 12.39% 13.84%
Preferred Stocks
0.00% 0.00% 7.86% 48.43%
Convertible Bonds
0.00% 0.00% 0.37% 29.22%

Stock Sector Breakdown

Weighting Return Low Return High XBMEX % Rank
Healthcare
98.99% 59.26% 100.00% 72.73%
Basic Materials
0.73% 0.00% 7.16% 12.99%
Financial Services
0.28% 0.00% 1.60% 10.39%
Utilities
0.00% 0.00% 0.00% 25.32%
Technology
0.00% 0.00% 22.69% 31.82%
Real Estate
0.00% 0.00% 5.89% 29.22%
Industrials
0.00% 0.00% 7.02% 31.17%
Energy
0.00% 0.00% 0.00% 25.32%
Communication Services
0.00% 0.00% 9.11% 28.57%
Consumer Defense
0.00% 0.00% 25.73% 34.42%
Consumer Cyclical
0.00% 0.00% 1.92% 31.17%

Stock Geographic Breakdown

Weighting Return Low Return High XBMEX % Rank
US
87.81% 66.06% 104.41% 67.92%
Non US
6.16% 0.00% 28.87% 37.74%

Bond Sector Breakdown

Weighting Return Low Return High XBMEX % Rank
Cash & Equivalents
100.00% 0.00% 100.00% 0.63%
Derivative
0.00% 0.00% 23.24% 42.77%
Securitized
0.00% 0.00% 0.00% 23.91%
Corporate
0.00% 0.00% 81.57% 34.78%
Municipal
0.00% 0.00% 0.00% 23.91%
Government
0.00% 0.00% 29.44% 24.64%

Bond Geographic Breakdown

Weighting Return Low Return High XBMEX % Rank
US
0.15% 0.00% 11.75% 13.84%
Non US
0.00% 0.00% 3.33% 26.42%

XBMEX - Expenses

Operational Fees

XBMEX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Expense Ratio 1.10% 0.08% 4.48% 47.80%
Management Fee 1.00% 0.03% 1.25% 90.57%
12b-1 Fee N/A 0.00% 1.00% N/A
Administrative Fee N/A 0.03% 0.25% N/A

Sales Fees

XBMEX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Front Load N/A 3.50% 5.75% N/A
Deferred Load N/A 1.00% 1.00% N/A

Trading Fees

XBMEX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Max Redemption Fee N/A 1.00% 1.00% N/A

Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

XBMEX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Turnover 49.00% 0.00% 238.00% 50.37%

XBMEX - Distributions

Dividend Yield Analysis

XBMEX Category Low Category High XBMEX % Rank
Dividend Yield 0.00% 0.00% 6.24% 54.09%

Dividend Distribution Analysis

XBMEX Category Low Category High Category Mod
Dividend Distribution Frequency Monthly Annual Quarterly Annual

Net Income Ratio Analysis

XBMEX Category Low Category High XBMEX % Rank
Net Income Ratio 0.01% -2.54% 1.85% 32.24%

Capital Gain Distribution Analysis

XBMEX Category Low Category High Capital Mode
Capital Gain Distribution Frequency Annually Semi-Annually Annually

Distributions History

View More +

XBMEX - Fund Manager Analysis

Managers

Erin Xie


Start Date

Tenure

Tenure Rank

Mar 28, 2005

17.19

17.2%

Ms. Xie is the managing director and Portfolio Manager of BlackRock Advisor since 2006. Before becoming part of BlackRock Advisors in 2005, she was with State Street Research & Management since 2001. Ms. Xie began her investment career as a pharmaceutical analyst for Sanford Bernstein in 1999.

Kyle McClements


Start Date

Tenure

Tenure Rank

Jun 20, 2012

9.95

10.0%

CFA ,Managing Director of BlackRock, Inc. since 2010 McClements joined BlackRock following the merger with SSRM in 2005. Prior to joining BlackRock, he was vice president of SSRM's Quantitative Strategies Group where one of his responsibilities was implementing different option strategies on various equity accounts since 2004. Prior to joining SSRM, McClements was a vice president at Deutsche Asset Management where he was a derivative, program and FX trader. From 1998 to 2001, he was also a portfolio manager for the ProEquity Fund Series.

Jeffrey Lee


Start Date

Tenure

Tenure Rank

Sep 14, 2012

9.72

9.7%

Mr. Lee joined DoubleLine Capital’s Global Developed Credit Group in 2012 as a corporate credit analyst. Prior to joining DoubleLine Capital, he was at Trust Company of the West for 17 years, which included 5 years as a corporate credit analyst and 5 years as a Money Market trader. He also held roles as an Economic Analyst and Fund Accountant.

Christopher Accettella


Start Date

Tenure

Tenure Rank

Sep 14, 2012

9.72

9.7%

Christopher M. Accettella, Director since 2008, Vice President of BlackRock, Inc. from 2005 to 2008,is a member of the Fundamental Equity platform within BlackRock's Portfolio Management Group. He is a trader responsible for executing equity derivatives and options trades. Prior to joining BlackRock in 2005, Mr. Accettella was an institutional sales trader with American Technology Research. From 2001 to 2003, he was with Deutsche Asset Management where he was responsible for derivatives and program trading. Prior to that, he was a senior associate in the Pacific Basin Equity Group at Scudder Investments Singapore Limited. Mr. Accettella began his investment career in 1997 as a portfolio analyst in the European Equity group of Scudder Kemper Investments, Inc. Mr. Accettella earned a BA degree in economics and Asian studies from Colgate University in 1997.

Xiang Liu


Start Date

Tenure

Tenure Rank

Sep 14, 2012

9.72

9.7%

Director of BlackRock since 2016. Prior to joining BlackRock in 2008, Mr. Liu was a Partner and Biotech Analyst at Mehta Partners. Mr. Liu began his investment career in 2000 and has a BS from the University of Science & Technology (China), an MBA from the University of Chicago and a PhD degree in Chemistry from Yale University.

Tenure Analysis

Category Low Category High Category Average Category Mode
0.02 24.72 7.88 0.25